- Country: Ukraine
- Summary: Glibenclamide 5 Mg Tablets; Levothyroxine 100 Mg Tablets; Metformin Film-Coated Tablets, 500 Mg Each; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge,...
- UAT Ref No: 130257934
- Deadline: 15 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 632658.72
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-12-014024-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Glibenclamide 5 mg tablets; Levothyroxine 100 mg tablets; Metformin film-coated tablets, 500 mg each; Human insulin (Medium-acting), suspension for injection, 100 U/ml, cartridge, 3 ml each; Human insulin (Combination: 30% Short duration of action; 70% of the average duration of action), suspension for injection, 100 Units/ml, cartridge, 3 ml each; Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml; Fluoxetine capsules/tablets of 20 mg; Haloperidol, solution for injections, 5 mg/ml, 1 ml each; Risperidone, tablets, 2 mg each; Haloperidol, tablets, 5 mg each; Povidone-iodine, solution for external use, 10%, 1000 ml each; Chlorhexidine, solution for external use 0.05% per 100 ml; Lactulose syrup 3.335g/5ml bottle 100 ml; Amiodarone, solution for injection, 50 mg/ml, 3 ml each; Amiodarone, tablets, 200 mg each; Sodium thiosulfate solution for injection 300mg/ml 5ml; Amitriptyline 25 mg tablets; Metoclopramide, solution for injection, 5 mg/ml, 2 ml each; Enalapril 5 mg tablets; Amlodipine 5 mg tablets; Diclofenac/lidocaine solution for injection 37.5 mg/10 mg per 2 ml; Lidocaine, solution for injection, 10 mg/ml, 3.5 ml each; Ceftriaxone, powder for injections of 1 g; Tranexamic acid solution for injection, 100 mg/ml in 5 ml; Hydroxyethyl starch (average molecular weight 200,000), 6%, 400 ml each; Fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Iodine, solution for external use, 5%, 20 ml each; Silver sulfadiazine, cream/ointment, 1%, 40 g each; Xi... Type of purchase: products Classifier and its corresponding code: DK 021:2015: 33600000-6 β Pharmaceutical products Diclofenac/lidocaine injection solution 37.5 mg/10 mg in 2 ml; Ofloxacin, J01MA01, Solution for infusions, 200 ml, 2 mg/ml, Container, Bottle, Vial, Package for infusion in in a protective bag, Polyvinyl chloride container in a polyethylene bag, ΠΠΠΠlibenclamide Levothyroxine sodium package... More Name Classifier and its corresponding code Quantity/Unit of measurement Pl...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGlibenclamide 5 Mg Tablets; Levothyroxine 100 Mg Tablets; Metformin Film-Coated Tablets, 500 Mg Each; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge,... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "MUNICIPAL HOSPITAL #4" OF ZAPORIZK CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Glibenclamide 5 Mg Tablets; Levothyroxine 100 Mg Tablets; Metformin Film-Coated Tablets, 500 Mg Each; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge,.... This tender is published on UkraineTenders under UAT Ref No: 130257934 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-16.
The estimated tender value is UAH 632658.72, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
